Solr Search

simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how the

ure disease. Both cell and gene therapies seek to modify genetic material to fight disease.

nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.

;the market and can identify multiple cancers early and simultaneously.

tionize clinical research. How can patient organizations support this movement? What are potential pitfalls to watch out for?

sometimes described as being “patient-centric.” Are they? What are the challenges and opportunities for patient groups to support them?

nical research, through preference studies and other patient insights, trial design and networks, recruitment and retention?

tanding racial and ethnic disparities in healthcare and research?

sses are significantly more likely to become infected with antibiotic-resistant bacteria than those without chronic disease.

ing-edge biomedical innovations to patients.